Parallax Volatility Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$722K Sell
800
-22,100
-97% -$22.4M ﹤0.01% 993
2025
Q4
$24.6M Sell
22,900
-39,400
-63% -$37.7M 0.05% 262
2025
Q3
$47.5M Buy
62,300
+26,700
+75% +$19.9M 0.07% 148
2025
Q2
$27.8M Sell
35,600
-102,400
-74% -$79.6M 0.06% 219
2025
Q1
$114M Sell
138,000
-123,600
-47% -$103M 0.31% 56
2024
Q4
$202M Buy
261,600
+216,700
+483% +$179M 0.39% 48
2024
Q3
$39.8M Buy
44,900
+37,600
+515% +$33.8M 0.07% 202
2024
Q2
$6.61M Sell
7,300
-41,600
-85% -$33.3M 0.01% 622
2024
Q1
$38M Sell
48,900
-3,700
-7% -$2.63M 0.09% 198
2023
Q4
$30.7M Buy
52,600
+22,500
+75% +$13.1M 0.06% 281
2023
Q3
$16.2M Sell
30,100
-1,200
-4% -$618K 0.04% 387
2023
Q2
$14.7M Sell
31,300
-3,200
-9% -$1.34M 0.03% 430
2023
Q1
$11.8M Sell
34,500
-13,100
-28% -$4.42M 0.02% 533
2022
Q4
$17.4M Sell
47,600
-12,200
-20% -$4.33M 0.03% 566
2022
Q3
$19.3M Buy
59,800
+28,400
+90% +$9M 0.03% 525
2022
Q2
$10.2M Sell
31,400
-31,500
-50% -$9.46M 0.01% 720
2022
Q1
$18M Sell
62,900
-71,900
-53% -$18.5M 0.01% 546
2021
Q4
$37.2M Sell
134,800
-122,100
-48% -$31M 0.04% 285
2021
Q3
$59.4M Sell
256,900
-42,600
-14% -$10.5M 0.06% 219
2021
Q2
$68.7M Buy
+299,500
New +$60.2M 0.09% 145
2021
Q1
Sell
-404,000
Closed -$68.2M 1794
2020
Q4
$68.2M Buy
404,000
+180,600
+81% +$27M 0.07% 232
2020
Q3
$33.1M Sell
223,400
-115,900
-34% -$17.9M 0.02% 540
2020
Q2
$55.7M Buy
339,300
+94,300
+38% +$14.5M 0.07% 237
2020
Q1
$34M Buy
245,000
+56,500
+30% +$7.76M 0.04% 271
2019
Q4
$24.8M Sell
188,500
-9,200
-5% -$1.07M 0.03% 370
2019
Q3
$22.1M Buy
197,700
+9,100
+5% +$1.01M 0.02% 368
2019
Q2
$20.9M Sell
188,600
-63,800
-25% -$7.51M 0.02% 345
2019
Q1
$32.8M Buy
252,400
+168,100
+199% +$20.4M 0.04% 228
2018
Q4
$9.76M Sell
84,300
-117,500
-58% -$13.1M 0.01% 519
2018
Q3
$21.7M Buy
+201,800
New +$20.2M 0.03% 274
2018
Q2
Sell
-30,000
Closed -$2.32M 2811
2018
Q1
$2.32M Buy
30,000
+5,000
+20% +$403K ﹤0.01% 727
2017
Q4
$2.11M Hold
25,000
﹤0.01% 901
2017
Q3
$2.14M Hold
25,000
﹤0.01% 828
2017
Q2
$2.06M Sell
25,000
-50,000
-67% -$4.08M ﹤0.01% 824
2017
Q1
$6.31M Hold
75,000
0.01% 509
2016
Q4
$5.52M Buy
+75,000
New +$5.59M 0.01% 613
2016
Q1
Sell
-263,600
Closed -$22.2M 3192
2015
Q4
$22.2M Buy
263,600
+66,300
+34% +$5.5M 0.05% 266
2015
Q3
$16.5M Buy
197,300
+157,400
+394% +$13.3M 0.04% 297
2015
Q2
$3.33M Sell
39,900
-69,200
-63% -$5.27M 0.01% 873
2015
Q1
$7.93M Sell
109,100
-536,000
-83% -$38.2M 0.02% 549
2014
Q4
$44.5M Buy
645,100
+489,300
+314% +$33M 0.13% 156
2014
Q3
$10.1M Buy
155,800
+78,500
+102% +$4.97M 0.03% 449
2014
Q2
$4.81M Sell
77,300
-212,400
-73% -$12.7M 0.02% 494
2014
Q1
$17.1M Sell
289,700
-14,200
-5% -$792K 0.1% 171
2013
Q4
$15.5M Sell
303,900
-3,000
-1% -$150K 0.08% 218
2013
Q3
$15.4M Buy
306,900
+5,800
+2% +$304K 0.08% 197
2013
Q2
$14.8M Buy
+301,100
New +$16.4M 0.07% 213

Other funds holding LLY

Parallax Volatility Advisers's LLY Position: Q1 2026 in Review

Parallax Volatility Advisers reduced its Eli Lilly (LLY) stake by 49% in Q1 2026, selling an estimated $3.32M and leaving 3,428 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #697.

Parallax Volatility Advisers first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. The position peaked at $56.7M in Q4 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Parallax Volatility Advisers held 3,428 shares of Eli Lilly worth $3.1M as of Q1 2026.
  • Parallax Volatility Advisers sold 3,277 Eli Lilly shares in Q1 2026, an estimated $3.32M.
  • Eli Lilly made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #697 holding.
  • Parallax Volatility Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
  • Parallax Volatility Advisers's Eli Lilly position peaked at $56.7M in Q4 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.